PAGE4 and posterior cortical atrophy: Furthermore, Sampson et al. [107] observed that in hormone-naive PCa, the median survival of patients with tumors expressing high PAGE4 levels was 8.2 years compared with 3.1 years for patients with tumors expressing negative/low levels of PAGE4 lending further credence to the model (Figure 4).